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Purpose: To report a case of acute quinine poisoning, document acute and chronic macular 
changes with optical coherence tomography imaging and fluorescein angiography (FA), and 
to review the literature on ocular toxicity of quinine.
Methods: A 32-year-old white female presented to our Emergency Department after ingesting 
over 7.5 g of quinine. She underwent a complete ophthalmologic examination, fluorescein 
angiography, Stratus time-domain optical coherence tomography (OCT), and electroretinography 
at 72 hours and 15 months postingestion. Stratus time-domain and Cirrus spectral-domain OCT, 
fundus autofluorescence, and FA were obtained at 28 months postingestion.
Results: Fluorescein angiography at 72 hours postingestion revealed normal filling times 
and vasculature. OCT showed marked thickening of the inner retina bilaterally. At 15 and 
28 months follow-up, fundus photography and fluorescein angiography demonstrated optic 
nerve pallor, severely attenuated retinal vessels while OCT showed inner retinal atrophy. Fundus 
autofluorescence did not reveal any retinal pigmentary abnormalities.
Conclusions: Quinine toxicity as seen by OCT reveals increased thickness with inner retinal 
hyperreflectivity acutely with development of significant retinal atrophy in the long-term. Fundus 
autofluorescence reveals an intact retinal pigment epithelial layer at 28 months. These findings 
suggest that quinine poisoning may produce a direct toxic effect on the inner retina in the acute 
phase resulting in long-term retinal atrophy.
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Introduction
Acute quinine poisoning is a devastating ocular event that can result in severe loss 
of vision.1 Quinine is an antimalarial agent that is often used for the treatment of 
restless legs syndrome. The drug has a narrow therapeutic range and carries the risk 
of multiple side effects such as cinchonism, hypoglycemia, arrhythmias, hemolysis, 
gastrointestinal intolerance, fever, and nephritis.2 In early 2007, the US Food and 
Drug Administration restricted the use of quinine solely to the treatment of malaria. 
Quinine has long been known to be toxic to the eye even at therapeutic levels, causing 
symptoms such as loss of vision, reduced color vision, and reduced visual fields.3,4 
Most visual symptoms occur after a quinine dose greater than 4 g and death can occur 
with doses exceeding 8 g.5
We describe a patient with profound visual loss after acute quinine poisoning. At 
72 hours postingestion, ERG, Stratus time-domain optical coherence tomography 
(OCT), fundus photography, and fluorescein angiography (FA) were performed on the 
patient. At 15 months postingestion, time-domain OCT and FA were again performed Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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on our patient. At the 28 months postingestion visit, Cirrus 
spectral-domain and Stratus time-domain OCT, FA, and 
fundus autofluorescence (FAF) were performed. To the 
best of our knowledge, this is the first documentation in the 
literature of the retinal changes in acute quinine toxicity as 
seen by OCT and FAF.
Case report
A 32-year-old white female presented to our Emergency 
Department five hours after attempting suicide by quinine 
overdose. The dose was estimated to be between 7.5 and 
10 g. On initial examination the patient was complaining 
of tinnitus, nausea, vomiting, as well as total loss of vision. 
Serum sodium and potassium were low at 133 mEq/L and 
3.6 mEq/L, respectively, and the patient’s ECG showed a 
prolonged QT interval. The patient was admitted to the medi-
cal intensive care unit of the Ohio State University Medical 
Center for monitoring and support.
Ophthalmology was consulted the following morning. 
The first ophthalmologic exam was performed at the 
bedside 23 hours postingestion and showed that the patient 
had no light perception in both eyes. The pupils were fixed 
and dilated at 8 mm. Fundoscopy revealed optic nerves 
with normal color and crisp margins, retinal vessels with 
normal course and caliber, and maculas with diffuse retinal 
thickening and bilateral cherry-red spots (CRS). Peripheral 
retinal examination was unremarkable OU. The patient 
received hyperbaric oxygen therapy per the recommendation 
of the medical intensive care unit team.
At 48 hours postingestion, the patient reported return of 
peripheral vision. Examination revealed partial resolution 
of the CRS with persistent retinal thickening. At 72 hours 
postingestion, the patient was medically stable enough to be 
transferred to the ophthalmology clinic. Fundoscopy revealed 
partial resolution of the CRS (Figure 1A, B). Fluorescein 
angiography showed normal filling times and no evidence 
of leakage or vascular staining (Figure 1C, D). Stratus time-
domain OCT revealed inner retinal hyperreflectivity with 
thickening in both eyes (Figure 2A, B). Central subfield 
thicknesses were 292 microns OD and 293 OS and macu-
lar   volumes for a 6 mm diagonal were 8.43 mm3 OD and 
8.75 mm3 OS. At this visit, bright flash ERG yielded reduced 
a-waves and absent b-waves, consistent with previous reports 
on the electrophysiologic effects of quinine poisoning.6
The patient was subsequently lost to follow-up for several 
months, as she was repeatedly hospitalized in   psychiatric 
institutions and underwent drug rehabilitation. Her first oph-
thalmologic follow-up examination was performed 15 months 
postingestion. At this visit, the patient’s   uncorrected visual acu-
ity (VA) was 20/20 OU. Although Zeiss-Humphrey 30-2 visual 
fields demonstrated normal foveal thresholds OU (33 dB OD, 
35 dB OS), they were constricted to 15 degrees OU. Dilated 
fundus examination revealed optic nerve pallor OU with retinal 
atrophy and severely attenuated retinal arterioles and venules 
(Figure 3A, B). However, normal arteriovenous transit times and 
arteriolar perfusion were demonstrated by fluorescein angiogra-
phy (Figure 3C, D). Stratus time-domain OCT revealed severe 
atrophy of the neuroretina in both eyes with central subfield 
thickness being 199 microns OD and 218 microns OS. Macular 
volumes for a 6 mm diagonal had decreased to 4.68 mm3 OD 
and 5.06 mm3 OS (Figure 4A, B).
The patient was last seen at the Ophthalmology clinic 
at 28 months postingestion. At this time, her uncorrected 
VA was 20/20 OD and 20/20 OS. Farnworth D-15 color 
vision testing demonstrated mild blue-yellow color defi-
ciencies. There were no changes worth noting between the 
patient’s Humphrey visual fields or FA between this visit 
and her visit at 15 months postingestion. Cirrus spectral-
domain OCT revealed central subfield thicknesses that were 
283 microns OD and 279 microns OS and average retinal 
thicknesses that were 213 microns OD and 211 microns OS 
(normal average retinal thickness is 264 ± 21.9 microns).7 
Although the central retinal thicknesses on the Cirrus OCT 
were within the normal range, the average macular thicknesses 
were decreased, a finding consistent with retinal atrophy and 
to the peripheral constriction seen on the visual fields. FAF 
photography (TRC-50DX; Topcon, Oakland, NJ) revealed 
a generalized hyperfluorescent pattern without evidence of 
atrophic retinal pigment epithelial changes (Figures 5, 6).
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Figure 1 Color fundoscopic images of right a) and left b) eyes 72 hours postingestion 
demonstrating retinal pallor and cherry red spots. Fluorescein angiograms of right 
c) and left d) eyes 72 hours postingestion revealing normal retinal vessels.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Discussion
The presentation and ophthalmologic clinical findings of this 
patient appear typical of quinine-induced ocular   damage. 
Previous case reports have demonstrated that patients usually 
develop loss of vision between 10 and 24 hours after ingestion 
of toxic levels of quinine. Most patients experience a return of 
central acuity with restricted visual fields over the next several 
weeks to months. Vessel attenuation and disk pallor seen at 
our patient’s 15- and 28-month examinations are consistent 
with the typical late fundus findings of quinine toxicity.5
Despite the compound’s well-established ocular   toxicity, 
the mechanism behind the damage it mediates is not entirely 
known. Towards this end, the acute OCT and FA findings in 
our patient were enlightening. At 72 hours postingestion, 
there was marked inner retinal hyperreflectivity with retinal 
thickening. This finding is consistent with OCT performed 
on the ischemic retina during central retinal artery   occlusion 
(CRAO).8 However, in our patient the FA in the acute stage 
demonstrated no abnormalities in arteriovenous transit 
and retinal perfusion. FAF at 28 months did not reveal 
any retinal pigment epithelium atrophic changes. Cirrus 
spectral-domain OCT demonstrates an intact external 
  limiting membrane as well as inner and outer segment of 
the photoreceptor layer at 28 months. These findings suggest 
that quinine poisoning produces damage that is confined to 
the inner retinal layers.
The presence of a CRS during the acute phase of quinine 
poisoning in our patient is consistent with previous reports of 
quinine overdose. CRS formation is seen with ischemia of the 
ganglion cell layer (GCL) in CRAO and in conditions where 
storage materials or metabolites accumulate in the GCL 
of the retina such as congenital gangliosidosis (Tay Sachs 
disease and Sandhoff’s disease), sphingolipidosis (Niemann-
Pick’s disease), glucocerebrosidosis (Gaucher’s disease), 
and with patients on long-term parenteral nutrition.9,10 In 
addition to quinine, CRS has also been observed with toxic 
interactions following intravitreal aminoglycoside injection, 
ingestion of dapsone, and ingestion of methanol.11–13 In a 
histopathologic report on primates, Conway et al reported 
that high doses of intravitreal gentamicin led to retinal 
toxicity with the formation of a CRS. The retinal toxicity was 
primarily confined to the inner retina with relatively intact 
photoreceptor and retinal pigment epithelial layers. In the 
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Figure 2 OCT images of the macula of the right a) and left b) eyes 72 hours postingestion demonstrating marked thickening and hyper-reflectivity of the inner retina.
Abbreviations: OCT, optical coherence tomography.
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Figure 3 Color fundoscopic images of right a) and left b) eyes 28 months postingestion 
showing attenuated retinal vessels and optic nerve pallor.  FA of the right c) and left 
d) eyes reveals attenuated vessels without evidence of perfusion deficits.
Abbreviations: FA, fluorescein angiography.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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acute phase, there was nerve fiber and ganglion cell swelling 
with subsequent atrophy of these layers in the chronic phase. 
They postulated that retinal toxicity was primarily due to a 
direct neurotoxic effect on the inner retina.14 This mechanism 
appears to be most consistent with the clinical, OCT, and FAF 
findings in our patient. The optic nerves do not appear to be 
affected in the early stages of toxicity as their appearance was 
unremarkable and there was no papillary leakage or staining 
on FA at 72 hours. In the latter stages of follow-up the pattern 
of visual field loss was one of generalized constriction rather 
than a cecocentral scotoma, a pattern more consistent with 
diffuse retinal rather than optic nerve toxicity.
Quinine has long been known to be neurologically active. 
Quinine is a Class IA anti-arrhythmic that blocks sodium 
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Figure 5 spectral OCT images of the right a) and left b) eyes 28 months postingestion showing atrophy of the neuroretina.
Abbreviations: OCT, optical coherence tomography.
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Figure 4 Time domain OCT images of the macula of the right a) and left b) eyes 28 months postingestion showing atrophy of the neuroretina.
Abbreviations: OCT, optical coherence tomography.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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and potassium channels in cardiac myocytes, causing a 
delay in the initiation of action potentials and increasing 
the action potential duration.15 Various studies have shown 
quinine capable of blocking voltage-gated outward potassium 
  channels, stimulating intracellular inositol-1,4,5-triphosphate 
production, and activating intracellular pathways via guanine 
nucleotide binding protein (G-protein)-coupled receptors.16–18 
These pharmacologic actions of quinine could be responsible 
for the clinical observations of rapid onset bilateral vision 
loss and eventual neuronal damage. Prolonged depolariza-
tion of the cell membrane can lead to depolarization of the 
mitochondrial membrane and stimulation of mitochondrial-
mediated apoptosis.19,20
Several proposed mechanisms of direct quinine-retina 
interaction exist in the literature. Aloisi et al postulated that 
retina damage is a result of free radicals generated by the 
photoionization of quinine.21 It has long been suspected 
that quinine blocks acetylcholine transmission in the retina. 
Recent evidence shows quinine to have an antagonistic 
effect on α9α10 nicotinic acetylcholine receptors else-
where in the body.22 Acetylcholine blockade can explain 
the immediate total blindness observed in quinine overdose, 
but does not explain how quinine leads to eventual cell 
death. Perhaps the most promising research concerning the 
mechanism of quinine toxicity involves gap junctions and 
connexins. Gap junctions are formed by structural proteins 
known as   connexins and allow for intracellular electrical 
communication by linking the cytosol of two consecutive 
cells and are found in gastrointestinal smooth muscle, 
cardiac muscle, and retinal cells. These tissue types are all 
affected in quinine poisoning. Studies in transfected mam-
malian cells have shown that quinine has the ability to act as 
a reversible, concentration-dependent gap junction channel 
blocker.23 Furthermore, quinine has been shown to block 
specific connexins, including connexin 36 (Cx36), which 
has been found in mouse and rat retinas.24,25 Cx36 gap 
junctions are responsible for excitatory and inhibitory 
interneuron communications between retinal ganglion cells 
and amacrine cells.26 The interaction of quinine with these 
junctions may help explain the acute blindness seen in qui-
nine toxicity and may also provide greater understanding 
of the mechanism of quinine’s neurotoxic effect.
Our clinical experience and recent literature   support the 
theory that quinine is directly neurotoxic to the inner retina. 
More research is needed to identify the exact mechanism 
by which quinine mediates direct neuronal cell death. 
  Interventions geared towards disrupting quinine’s toxic 
  neuronal activity would perhaps be able to prevent the dev-
astating loss of vision associated with this agent.
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